Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

1 May 2003

Abstract excerpt

Gene replacement therapy is an attractive approach for treatment of genetic disease, but may be complicated by the risk of a neutralizing immune response to the therapeutic gene product. There are examples of humoral and cellular immune responses against the transgene product as well as absence of such responses, depending on vector design and the underlying mutation in the dysfunctional gene. It has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemophilia Treatment and Research
Share to RNA Interference and Gene Delivery
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12727926
DOI: 10.1172/jci16887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferPMID 12727926Read ↗

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferSemantic proximity Read ↗

Tolerance Induction by Viral In Vivo Gene TransferSemantic proximity Read ↗

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia ASemantic proximity Read ↗

Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene ProductsSemantic proximity Read ↗

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in miceSemantic proximity Read ↗

Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene TherapySemantic proximity Read ↗

Nonredundant Roles of IL-10 and TGF-β in Suppression of Immune Responses to Hepatic AAV-Factor IX Gene TransferSemantic proximity Read ↗

Muscle as a Target for Supplementary Factor IX Gene TransferSemantic proximity Read ↗

Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IXSemantic proximity Read ↗

Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BSemantic proximity Read ↗

Development of gene transfer for induction of antigen-specific toleranceSemantic proximity Read ↗

Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.